Ionis Pharmaceuticals to Host Investor Day
CARLSBAD, Calif., /PRNewswire/ -- Ionis Pharmaceuticals, Inc.(NASDAQ: IONS), the leader in antisense therapeutics, today announced that management will host an Investor Day on Friday, December 7th at 7:30 a.m. Eastern Time at Marriott East Side in New York, NY.
The agenda for the meeting is as follows:
To register to attend the event, please visit the Investors & Media page at www.ionispharma.com, enter your information and select "Attending Live Event" from the dropdown menu.
A live audio webcast of the presentation will be available on the Investors & Media section of the Company's website. A replay of the presentation will be available on the website within 48 hours and will be archived for a limited time.
ABOUT IONIS PHARMACEUTICALS, INC.
Our sights are set on all the patients we have yet to reach with a pipeline of more than 40 drugs with the potential to treat patients with cardiovascular disease, rare diseases, neurological diseases, infectious diseases and cancer. We created TEGSEDI™ (inotersen) the world's first RNA-targeted therapeutic approved for the treatment of polyneuropathy of hereditary transthyretin (TTR) amyloidosis (ATTR) in adult patients that our affiliate Akcea Therapeutics is commercializing. Together with Akcea, we are also bringing new medicines to patients with cardiometabolic lipid disorders.
To learn more about Ionis follow us on twitter @ionispharma or visit http://ir.ionispharma.com/.
*Spinraza is marketed by Biogen.
IONIS' FORWARD-LOOKING STATEMENT
In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" refers to Ionis Pharmaceuticals and its subsidiaries.
Ionis Pharmaceuticals™ is a trademark of Ionis Pharmaceuticals, Inc. Akcea Therapeutics™ is a trademark of Akcea Therapeutics, Inc. TEGSEDI™ is a trademark of Akcea Therapeutics, Inc. WAYLIVRA™ is a trademark of Akcea Therapeutics, Inc. SPINRAZA® is a registered trademark of Biogen.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ionis-pharmaceuticals-to-host-investor-day-300747060.html
SOURCE Ionis Pharmaceuticals, Inc.
Company Codes: NASDAQ-NMS:IONS